Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Protagonist Therapeutics, Inc. PTGX

Set alert

Price alert · PTGX

All alert types
142.26 USD +2.89 +2.07%

As of Nov 3, 1:23 PM ET

Bid
142.01 × 2
Ask
142.38 × 2
140.73 Day range 144.27
75.44 52-week range 160.81
YTD
+62.88%
1 year
+87.31%
Open
140.73
Prev close
139.37
Mkt cap
9.21B
Vol
148.27K
Avg vol
645.60K
EPS
1.03
P/E
138.12
Div yield
0.00%
More statistics
Low
140.73
High
144.27
Forward P/E
-1404.09
Beta
1.22
Short ratio
12.29
Inst. own
119.68%
Dividend
0.00
Ex-div date
Earnings
Nov 5, 2026
50-d avg
142.93
200-d avg
116.62
1y target
178.57

5D chart

Chart tools
Interval
1m5m15m30m

Signals (116)
NameTimeAgo
SMA: BullishNov 3, 9:30 AM3 hours ago
SMA: BullishNov 3, 9:30 AM3 hours ago
MACD: Buy SignalNov 3, 9:30 AM3 hours ago
SMA: BearishNov 2, 3:50 PM21 hours ago
SMA: BearishNov 2, 3:50 PM21 hours ago
MACD: Sell SignalNov 2, 3:50 PM21 hours ago
SMA: BullishNov 2, 3:45 PM21 hours ago
SMA: BullishNov 2, 3:45 PM21 hours ago
MACD: Buy SignalNov 2, 3:40 PM21 hours ago
MACD: Sell SignalNov 2, 3:35 PM21 hours ago
SMA: BearishNov 2, 3:20 PM22 hours ago
SMA: BearishNov 2, 3:15 PM22 hours ago
SMA: BullishNov 2, 3:05 PM22 hours ago
SMA: BearishNov 2, 3:00 PM22 hours ago
SMA: BullishNov 2, 2:55 PM22 hours ago
SMA: BullishNov 2, 2:50 PM22 hours ago
MACD: Buy SignalNov 2, 2:50 PM22 hours ago
MACD: Sell SignalNov 2, 1:40 PM23 hours ago
SMA: BearishNov 2, 1:30 PM23 hours ago
SMA: BullishNov 2, 1:25 PM23 hours ago

Newest 20 of 116.

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 178.57 +25.5% upside
Target (low)
149.00
Target (mean)
178.57
Target (high)
225.00
Ratings (0m) 14 14 buy · 0 hold · 0 sell
  • Strong buy3
  • Buy11
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 14
  • 1 month ago 13
  • 2 months ago 13

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

PTGX analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter2.660.13043 – 3.40-0.62+529.2%241.32M+5021.4%12
Next quarter-0.50438-0.95174 – 0.45-0.69+26.9%33.28M+347.5%11
Current year4.773.52 – 5.74-2.05+332.5%549.03M+1093.1%13
Next year-0.09926-2.80 – 5.454.77-102.1%215.49M-60.8%13

Upgrades and downgrades

The latest rating changes

PTGX analyst upgrades and downgrades
DateFirmActionFromTo
Oct 21, 2026TD CowenMaintainedBuyBuy
Oct 12, 2026UBSInitiated—Buy
Sep 1, 2026BarclaysMaintainedOverweightOverweight
Sep 1, 2026BMO CapitalMaintainedOutperformOutperform
Aug 31, 2026CitigroupMaintainedBuyBuy
Aug 31, 2026HC Wainwright & Co.MaintainedBuyBuy
Aug 17, 2026BMO CapitalMaintainedOutperformOutperform
Aug 10, 2026Truist SecuritiesMaintainedBuyBuy
Aug 10, 2026WedbushMaintainedOutperformOutperform
Aug 10, 2026Goldman SachsUpgradeNeutralBuy
Aug 6, 2026CitigroupMaintainedBuyBuy
Aug 6, 2026BarclaysMaintainedOverweightOverweight
Jul 14, 2026BarclaysMaintainedOverweightOverweight
Jul 7, 2026Truist SecuritiesMaintainedBuyBuy
May 10, 2026CitigroupMaintainedBuyBuy
May 6, 2026CitizensMaintainedMarket OutperformMarket Outperform
May 6, 2026WedbushMaintainedOutperformOutperform
Apr 15, 2026Truist SecuritiesMaintainedBuyBuy
Apr 7, 2026Clear StreetMaintainedBuyBuy
Mar 19, 2026Leerink PartnersMaintainedOutperformOutperform
Mar 19, 2026JP MorganMaintainedOverweightOverweight
Mar 19, 2026CitigroupMaintainedBuyBuy
Mar 19, 2026BarclaysMaintainedOverweightOverweight
Mar 3, 2026Goldman SachsMaintainedNeutralNeutral
Feb 26, 2026TD CowenMaintainedBuyBuy
Feb 26, 2026BarclaysMaintainedOverweightOverweight
Feb 26, 2026CitizensMaintainedMarket OutperformMarket Outperform
Feb 2, 2026JefferiesMaintainedBuyBuy
Jan 30, 2026HC Wainwright & Co.MaintainedBuyBuy
Jan 5, 2026Truist SecuritiesMaintainedBuyBuy